Lv75
3500 积分 2024-03-07 加入
Separate Evaluation of Fraction Absorbed and Intestinal Availability after Oral Administration of Drugs Based on the Measurement of Portal and Systemic Plasma Concentrations and Luminal Concentration
10天前
已完结
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling
1个月前
已完结
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider
2个月前
已完结
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization towards orally available bifunctional protein degraders
3个月前
已完结
An update on the importance of plasma protein binding in drug discovery and development
3个月前
已完结
Bridging in vitro and clinical data: Experimental insights into the IC50 variability of dolutegravir as an organic cation transporter 2 inhibitor
3个月前
已关闭
Cerivastatin-induced rhabdomyolysis in a renal transplant on cyclosporin
3个月前
已关闭
Carboxylated/Oxidized Diamond Nanoparticles for Quantifying Immunoglobulin G Antibodies Using Mass Spectrometry
10个月前
已完结
皖公网安备34019202002308
